Moreover, MASLD patients have a marked endothelial NO synthase dysfunction54 which might be accounted for by an altered insulin signalling caused by insulin resistance, a common finding in MASLD patients.55 The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.